Cerebral and Pulse Oximeter Market Scope
Cerebral oximeters measure tissue oxygen saturation, it reflexes hemoglobin saturation in arterial, venous, and capillary blood. Cerebral oximetry values reflect a balance between oxygen consumption and oxygen delivery to the brain. Variations in oxygen level may lead to several complications such as hypoxia, Polycythemia, which is an increased production of red blood cells. Polycythemia increases the risk of clotting and can hurt brain function. Hence to prevent brain damage, heart failure, and death continuous monitoring of oxygen levels in the blood is needed. Increase in incidence of respiratory and cardiovascular diseases, rising adoption in homecare settings, growing use of patient monitoring devices in hospitals, and launch of the convenient fingertip and wrist oximeter.
|Unit||Value (USD Million)|
|Key Companies Profiled||Acare Technology Co. Ltd. (China), GE healthcare (United States), Smiths Medical (United States), Masimo Corporation (Switzerland), Medtronic PLC (Ireland), Koninklijke Philips N.V. (Netherlands), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Nihon Kohden (Japan), American Diagnostic Corporation (United States) and Shenzhen Greatmade Tech Limited (China)|
Competition among existing players is due to the stiff market share occupied by leading players. The industry leader is engaged in offering innovative and superior-quality products to cater to the ever-growing demand for cerebral and pulse oximeters. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Cerebral and Pulse Oximeter market throughout the predicted period.
Acare Technology Co. Ltd. (China), GE healthcare (United States), Smiths Medical (United States), Masimo Corporation (Switzerland), Medtronic PLC (Ireland), Koninklijke Philips N.V. (Netherlands), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Nihon Kohden (Japan), American Diagnostic Corporation (United States) and Shenzhen Greatmade Tech Limited (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Nonin Medical Inc. (United States), Sigowill Bio Meditech Limited (China), Edwards Lifesciences Corporation (United States) and RossMax International Inc. (United States).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global Cerebral and Pulse Oximeter market by Type , by Application (Surgical, Monitoring and Others) and Region with country level break-up.
On the basis of geography, the market of Cerebral and Pulse Oximeter has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.
Market Leaders and their expansionary development strategiesIn September, GE Healthcare acquired BK Medical, Expanding Ultrasound portfolio into surgical visualization. BK Medical is an innovator in global intraoperative imaging and surgical navigation, used to guide clinicians during minimally invasive and robotic surgeries and to visualize deep tissue during procedures in neuro and abdominal surgery
In March 2022, the introduction of ipulseOx has been announced by smart Meter, a manufacturer of patient monitoring equipment. The first cell phone-connected pulse oximeter offers remote patient monitoring services for long-term diseases like heart disease and chronic obstructive pulmonary disease.
Influencing Trend:Cerebral oximetry assesses relative trends of cerebral tissue oxygenation
Market Growth Drivers:Increase in technological advancements in cerebral and pulse oximeter
Challenges:Lack of awareness of the disease
Restraints:Inaccuracy of results showing in cerebral and pulse
Opportunities:Increase in Incidence of cardiac and respiratory disorders
Key Target AudienceCerebral and pulse oximeter Manufacturers Suppliers and Distributors, Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations and End-Use Industries